The long-term follow-up of patients with endoscopically diagnosed reflux oesophagitis with specific emphasis to complaints

被引:6
|
作者
Loffeld, Susan M. L. A. [2 ]
Dackus, Gwen M. H. E. [2 ]
Loffeld, Ruud J. L. F. [1 ]
机构
[1] Med Ctr, Dept Internal Med Zaans, Zaandam, Netherlands
[2] Univ Maastricht, Zaandam, Netherlands
关键词
gastroesophageal reflux disease; long-term treatment; proton pump inhibitor; reflux oesophagitis; treatment; RELAPSE; EFFICACY; THERAPY; DISEASE; SAFETY;
D O I
10.1097/MEG.0b013e32834b8d18
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction Patients with gastroesophageal reflux disease (GERD) need long-term treatment with acid-suppressive therapy. Data on long-term follow-up are very rare. For this reason, a study was performed to detect complaints many years after diagnosis. Patients and methods All patients diagnosed with reflux oesophagitis in the years 1998-2000 were included. In the summer of 2010, they received a questionnaire with four different lists of questions pertaining to reflux complaints and use of medication. Severity and frequency were scored on 5-point and 6-point Likert scales, respectively; the GerdQ, a symptom activity index, and the gastrointestinal symptom-rating scale were also used. Results Complaints were reported by 130 patients (63%); the majority of these, 115 (88%), used acid suppressive therapy. Only 78 patients were in clinical remission, with or without therapy. The respondents with complaints were divided into two groups. Group 1: all patients with reflux complaints using acid suppressive therapy. Group 2: all patients with complaints without medication. Patients in group 1 were significantly older at the time of the endoscopic diagnosis compared with patients of group 2, and patients in group 1 had a hiatal hernia more often (P < 0.001). There was no difference in the overall symptom or the frequency score per patient between both groups, with a mean of 5.97 versus 6.8 and 13.4 versus 13.8 respectively. However, heartburn, nausea, acid regurgitation, epigastric pain, dysphagia and nocturnal complaints showed a significantly higher prevalence in patients of group 2. Scores for specific complaints were significantly lower in group 2 and there was no difference between the GerdQ, the symptom activity index and the gastrointestinal symptom-rating scale. Conclusion Despite effective therapy, only 37% of the patients are in complete remission. However, the individual symptom score is rather low. Patients without medication more often have reflux complaints but lower severity scores. Patients who still had complaints and used medication had a hiatal hernia significantly more often. Eur J Gastroenterol Hepatol 23:1122-1126 (C) 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins.
引用
收藏
页码:1122 / 1126
页数:5
相关论文
共 50 条
  • [21] Long-Term Clinical Follow-Up of Patients With Chronic Rhinosinusitis
    Thunberg, Ulrica
    Saber, Amanj
    Soderquist, Bo
    Hugosson, Svante
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2021, 130 (05): : 504 - 512
  • [22] Long-Term Follow-up of Patients With Autonomous Thyroid Nodules Treated With Radioiodine
    Moroto, Debora
    Torquato-Vieira, Isabel C. O.
    Fiorin, Lia B.
    Camacho, Cleber P.
    Castiglioni, Mario Luiz V.
    Maciel, Rui M. B.
    Furlanetto, Reinaldo P.
    Matsumura, Luiza K.
    Janovsky, Carolina C. P. S.
    Lindsey, Susan C.
    Martins, Joao Roberto M.
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (06) : 529 - 535
  • [23] Long-Term Follow-Up of Pediatric Patients Treated with Mitoxantrone for Multiple Sclerosis
    Kornek, B.
    Bernert, G.
    Rostasy, K.
    Mlczoch, E.
    Feucht, M.
    Prayer, D.
    Vass, K.
    Seidl, R.
    NEUROPEDIATRICS, 2011, 42 (01) : 7 - 12
  • [24] The long-term follow-up of patients with thionamide-treated Graves' hyperthyroidism
    Bandai, Sachiko
    Okamura, Ken
    Fujikawa, Megumi
    Sato, Kaori
    Ikenoue, Hiroshi
    Kitazono, Takanari
    ENDOCRINE JOURNAL, 2019, 66 (06) : 535 - 545
  • [25] Long-term follow-up of HIV-infected patients on dolutegravir monotherapy
    Tebano, G.
    Soulie, C.
    Schneider, L.
    Blanc, C.
    Agher, R.
    Seang, S.
    Valantin, M. A.
    Palich, R.
    Tubiana, R.
    Peytavin, G.
    Marcelin, A. G.
    Assoumou, L.
    Katlama, C.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (03) : 675 - 680
  • [26] Long-term follow-up study of the Stretta procedure for the treatment of gastroesophageal reflux disease
    Torquati, A
    Houston, HL
    Kaiser, J
    Holzman, MD
    Richards, WO
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2004, 18 (10): : 1475 - 1479
  • [27] Long-term follow-up study of the Stretta procedure for the treatment of gastroesophageal reflux disease
    A. Torquati
    H. L. Houston
    J. Kaiser
    M. D. Holzman
    W. O. Richards
    Surgical Endoscopy And Other Interventional Techniques, 2004, 18 : 1475 - 1479
  • [28] Long-term follow-up of children with refractory immune thrombocytopenia treated with rituximab
    Matsubara, Kousaku
    Takahashi, Yoshiyuki
    Hayakawa, Akira
    Tanaka, Fumiko
    Nakadate, Hisaya
    Sakai, Michio
    Maeda, Naoko
    Oka, Toshiaki
    Ishii, Eiichi
    Bessho, Fumio
    Morimoto, Tsuyoshi
    Goto, Hiroaki
    Hashii, Yoshiko
    Hatakeyama, Naoki
    Shirahata, Akira
    Imaizumi, Masue
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (04) : 429 - 436
  • [29] A long-term follow-up of Eales' disease
    Atmaca, LS
    Batioglu, F
    Sonmez, PA
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2002, 10 (03) : 213 - 221
  • [30] Long-term follow-up of lipid-lowering trials
    Packard, Chris J.
    Ford, Ian
    CURRENT OPINION IN LIPIDOLOGY, 2015, 26 (06) : 572 - 579